For research use only. Not for therapeutic Use.
MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1].
| Catalog Number | I031562 |
| CAS Number | 2070931-57-4 |
| Synonyms | 7-(4-fluoro-2-methoxyphenyl)-6-methyl-N-(1-piperidin-4-ylpyrazol-4-yl)thieno[3,2-d]pyrimidin-2-amine |
| Molecular Formula | C22H23FN6OS |
| Purity | ≥95% |
| InChI | InChI=1S/C22H23FN6OS/c1-13-20(17-4-3-14(23)9-18(17)30-2)21-19(31-13)11-25-22(28-21)27-15-10-26-29(12-15)16-5-7-24-8-6-16/h3-4,9-12,16,24H,5-8H2,1-2H3,(H,25,27,28) |
| InChIKey | AVIOBQFPAGEICQ-UHFFFAOYSA-N |
| SMILES | CC1=C(C2=NC(=NC=C2S1)NC3=CN(N=C3)C4CCNCC4)C5=C(C=C(C=C5)F)OC |
| Reference | [1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
